Abstract
Uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) is involved in catalyzing estrogen, the hormone that plays a central role in the etiology of breast cancer. A common polymorphism [A(TA)6TAA (allele *1) to A(TA)7TAA change (allele *28)] in the TATA-box of the promoter region of the UGT1A1 gene has been reported to be associated with a reduced transcription of this gene. We investigated the association of this polymorphism with the risk of breast cancer among 1047 breast cancer cases and 1083 community controls in the Shanghai Breast Cancer Study, a population-based case-control study. Approximately same proportion of cases (12.5%) and controls (13.0%) carried the variant allele *28 in the Chinese population (p= 0.32). When stratified by age, carrying the *28 allele was associated with an increased risk of breast cancer among women aged less than 40 years (odds ratio [OR] = 1.7; 95% CI = 1.0–2.7) but not among women 40 years old and over (OR = 0.8; 0.7–1.1). Only a few women were homozygous for the *28 allele, precluding a detailed gene-dose association analysis. Additional analyses showed that, the elevated risk associated with the UGT1A1*28 allele among young women was primarily seen in women who had a later menarche, short menstrual years, absence of family history of breast cancer, low waist-to-hip ratio, or low body-mass index. These results suggested that the *28 allele in the UGT1A1 gene may be associated with an increased risk for breast cancer among Chinese women under age 40. No significant associations were observed with *28 allele and breast cancer risk by estrogen receptor/progesterone receptor status.
Similar content being viewed by others
References
Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF: Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102: 172–178, 2002
Guillemette C, Millikan RC, Newman B, Housman DE: Genetic polymorphisms in uridine diphosphoglucuronosyltransferase 1A1 and association with breast cancer among African-Americans. Cancer Res 60: 950–956, 2000
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS: A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190–197, 1995
Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, Strax P, Pasternack BS: Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol Biomar Prev 4: 857–860, 1995
Belanger A, Hum DW, Beaulieu M, Levesque E, Guillemette C, Tchernof A, Belanger G, Turgeon D, Dubois S: Characterization and regulation of UDP-glucuronosylytransferases in steroid target tissues. J Steroid Biochem Mol Biol 65: 301–310, 1998
Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW: The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7: 255–269, 1997
Kaplan M, Hammerman C, Beutler E: Heterozygosity for a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 35: 148–151, 2001
Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, Hunter DJ: Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomar Prev 10: 711–714, 2001
Strassburg CP, Manns MP: Jaundice, genes and promoters. J Hepatol 33: 476–479, 2000
Lin JP, Cupples LA, Wilson PWF, Heard-Costa N, O'Donnell CJ: Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham Study. Am J Hum Genet 72: 1029–1034, 2003
Burchell B, Hume R: Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol 14: 960–966, 1999
Taioli E, Garte SJ, Trachman J, Garbers S, Sepkovic DW, Osborne MP, Mehl S, Bradlow HL: Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 88: 617, 1996
Tukey RH, Strassburg CP: Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40: 581–616, 2000
Ademuyiwa FO, Olopade OI: Racial differences in genetic factors associated with breast cancer. Cancer Metastas Rev 22: 47–53, 2003
Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomar Prev 10: 483–488, 2001
Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO, Chen JR, Pan XY, Shrubsole M, Zheng W: Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomar Prev 10: 1207–1211, 2001
Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT: Genetic polymorphism of cytochrome p450-1B1 and risk of breast cancer. Cancer Epidemiol Biomar Prev 9: 147–150, 2000
Xie DW, Shu XO, Deng ZL, Wen WQ, Creek KE, Dai Q, Gao YT, Jin F, Zheng W: A population-based case-control study of HER-2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 92: 412–417, 2000
Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, Sellers TA, Kushi LH, Ruan Z, Bostick RM, Jin F, Zheng W: Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai breast cancer study. Int J Cancer 87: 295–300, 2000
Fetrin KY, Gonçalves MS, Saad STO, Costa FF: Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet 108: 117–119, 2002
Balram C, Sabapathy K, Fei G, Khoos KS, Lee EJD: Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*8 is a common allele in Indians. Pharmacogenetics 12: 81–83, 2002
Ando Y, Chida M, Nakayama K, Saka H, Kamataki T: The UGT1A*28 allele is relatively rare in a Japanese population. Pharmacogenetics 8: 357–360, 1998
Lampe JW, Bigler J, Horner NK, Potter JD: UDP-glucuronosyltransferase (UGT1A*28 and UGT1A*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 9: 341–349, 1999
Beutler E, Gelbart T, Demina A: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95: 8170–8174, 1998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adegoke, O.J., Shu, X.O., Gao, YT. et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 85, 239–245 (2004). https://doi.org/10.1023/B:BREA.0000025419.26423.b8
Issue Date:
DOI: https://doi.org/10.1023/B:BREA.0000025419.26423.b8